In vivo study of experimental pneumococcal meningitis using magnetic resonance imaging

Christian T Brandt1, Helle Simonsen, Matthew Liptrot

  • 1National Center for Antimicrobials and Infection Control, Statens Serum Institut, Copenhagen, Denmark. ctb@ssi.dk

BMC Medical Imaging
|January 16, 2008
PubMed
Abstract

Insights

Magnetic Resonance Imaging (MRI) effectively tracked experimental meningitis in rats. The study identified increased blood-brain-barrier permeability and ventricle size as key markers of disease progression.

Area of Science:

  • Neuroimaging
  • Infectious Diseases
  • Experimental Medicine

Background:

  • Experimental meningitis studies require robust methods to track disease progression.
  • Identifying pathophysiological markers is crucial for evaluating new treatment strategies.

Purpose of the Study:

  • To evaluate Magnetic Resonance Imaging (MRI) methods for studying experimental meningitis.
  • To identify and characterize pathophysiological parameters that change during meningitis progression.

Main Methods:

  • Rats with S. pneumoniae meningitis underwent various MRI sequences (T1W, T2W, diffusion, contrast-enhanced) at multiple time points.
  • Dynamic MRI (dMRI) assessed blood-brain-barrier (BBB) permeability and perfusion.
  • Clinical scores, bacterial, and white blood cell (WBC) counts were also measured.

Main Results:

  • MRI revealed significant increases in BBB permeability and ventricle size in infected rats.
  • Clinical disease severity correlated with ventricle expansion.
  • Muscle perfusion decreased, indicating sepsis, while brain water distribution showed heterogeneous changes.

Conclusions:

  • In-vivo MRI successfully monitored the evolution of bacterial meningitis in rats.
  • Increasing BBB breakdown and ventricle size were key MRI findings.
  • MRI is a valuable tool for future studies evaluating adjunctive meningitis treatments.